DP303c in Patients With HER2-positive Advanced Breast Cancer
Clinical trial NCT05901935 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05901935
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-01-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.